Press Releases

  • MOORESTOWN, N.J., May 30, 2018 — Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety by deploying new, medication risk mitigation software solutions and proprietary medication decision support tools, announced two new executives have joined its corporate team. Kim Browning, CHC, PMP, is TRHC’s new Executive Vice President (EVP) responsible for TRHC subsidiary company, Capstone Performance Systems and its new division that resulted from the recent acquisition of Peak Health Plan
  • MOORESTOWN, N.J., May 30,2018 – Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company optimizing medication safety by deploying new, medication risk mitigation software solutions and proprietary medication decision support tools, announced two new executives have joined its corporate team. Kim Browning, CHC, PMP, is TRHC’s new Executive Vice President (EVP) responsible for TRHC subsidiary company, Capstone Performance Systems and its new division that resulted from the recent acquisition of Peak Health Plan
  • Explore answers to commonly asked questions, and build upon other best practices. Q: Are there pre-populated recommendations within MedWise™ (MW)? A: Yes. The five MW pre-populated recommendations are anticholinergic cognitive burden, sedative burden, NSAID, PPI, and CYP2D6 opioid. The only pre-populated recommendation that relates to competitive inhibition is for CYP2D6 opioid.  The NSAID and PPI recommendations relate to risks associated with prolonged use. Q: How will the pre-populated recommendations in MW help me? A: The
  • Greetings, EMTM Pharmacist Participants, When I was a young community pharmacist entrepreneur, I thought my professional life was akin to a sprint. As I matured, I found that my professional life was more of a marathon – a bit more patience was needed to hone the pharmaceutical care processes. Maybe you can relate? As we initiate our exploration with you of a new way to apply Pharmacokinetic/Pharmacodynamic (PK/PD) science to practice, the watchword for our
  • MOORESTOWN, N.J., May 25, 2018 — Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC) President Orsula V. Knowlton, PharmD, MBA, was inducted into the College of Physicians of Philadelphia at College Night Gala held May 4, 2018. Known as the “birthplace of American Medicine,” the College of Physicians, founded in 1787, is one of the oldest professional medical organizations in the country. Its mission as a non-profit is “to promote the heritage and future of health and
  • MOORESTOWN, N.J., May 09, 2018 — Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety by deploying new, medication risk mitigation software solutions and novel, proprietary medication decision support tools, has completed a study of the feasibility of a pharmacist-led pharmacogenomics (PGx) service for the federal Program of All-inclusive Care for the Elderly (PACE). Entitled, “Implementation of a Pharmacist-Led Pharmacogenomics Service for PACE (PHARM-GENOME-PACE)”, the article was published online March 5,
  • ST. LOUIS, MO, and MOORESTOWN, NJ, May 03, 2018 — Tabula Rasa HealthCare (NASDAQ:TRHC), a healthcare technology company offering comprehensive data-driven software solutions and services for healthcare organizations, today announced it has acquired Peak PACE Solutions, the leading health plan management solutions and services provider in the PACE (Program of All-inclusive Care for the Elderly) market. Peak PACE Solutions will become Peak Health Plan Management Services, and operate as a service of Capstone Performance Systems,
  • MOORESTOWN, N.J., April 30, 2018 — CareKinesis, a subsidiary of Tabula Rasa HealthCare (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, recently signed an agreement with SpiriTrust Lutheran LIFE (Living Independence for the Elderly) to provide personalized medication safety, proprietary technology, and pharmacy adherence packaging that uses science to predict and avoid multi-drug interactions for SpiriTrust’s participants. LIFE is a Medicare and Medicaid program known in many states as PACE, Program of
  • BOSTON, April 24, 2018 — AMCP Annual Meeting – Tabula Rasa HealthCare, Inc., (TRHC) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced its Optimized Opioid Solution™ to identify and prevent unintentional opioid misuse and avoid unintentional overdose. In the U.S., at least half of all opioid overdose deaths involve a prescribed opioid medication, and nearly 80% of those deaths are considered accidental or unintentional. When opioids are taken at the
  • MOORESTOWN, N.J., April 23, 2018– Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety, announced today that subsidiary SinfoníaRx has published its 2018 Program Performance Report, presenting a comprehensive analysis of calendar-year 2017. “Our Annual Program Performance Report not only serves as an opportunity to reflect on our achievements throughout 2017, but also presents a platform to highlight the capabilities of our innovative healthcare solutions,” says SinfoníaRx CEO, Kevin Boesen, PharmD.